1,3-Benzenedicarboxamide, 5-amino-N1,N3-bis(2,3-dihydroxypropyl)-, hydrochloride (1:1)


List details

Registration details

REACH registration record Registered substances
Record ID 100.102.026
Info Page external link [echa.europa.eu]
Factsheet URL external link [echa.europa.eu]
Last updated 10-12-2020
Tonnage band Intermediate use only
Submission type Joint
Registration type Intermediate
Registration status Active

Lead registrant

GE Healthcare AS


Registrant Address
GE Healthcare AS Nycoveien 1 Postboks 4220 Nydalen 0401 Oslo Oslo Norway
IVICT Europe GmbH Kennedydamm 19 40476 Düsseldorf Germany
Justesa Imagen S.A.U. Avenida de San Pablo 27 28823 Coslada Madrid Spain

Related substances

By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.

Related regulatory records

Record history

The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.

This version
Oct. 15, 2021
  • Registrants / Address: Avenida de San Pablo 27 28823 Coslada Madrid SpainAvenida de San Pablo 27 28823 Coslada Madrid Spain
  • Registrants / Address: Kennedydamm 19 40476 Düsseldorf GermanyKennedydamm 19 40476 Düsseldorf Germany
May 28, 2021
  • Name: 5-Amino-N,N'-bis(2,3-dihydroxypropyl)-1,3-phthaldiamidehydrochloride1,3-Benzenedicarboxamide, 5-amino-N1,N3-bis(2,3-dihydroxypropyl)-, hydrochloride (1:1)
  • CAS: 203515-86-0
  • Related internal registration record ID: 243129279621
Jan. 12, 2021
  • Last updated: 04-05-202010-12-2020
  • Related internal registration record ID: 202531243129
  • Registration status: Active
  • Tonnage band: Intermediate Use OnlyIntermediate use only
Dec. 2, 2020
  • Last updated: 04-05-2020
  • Related internal registration record ID: 93156202531
  • Record ID: 100.102.026
Add any of the related substances to your watchlist to monitor this regulatory record.